Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by VancDayTraderon Aug 14, 2013 9:35am
335 Views
Post# 21668972

SeeThruEquity

SeeThruEquitySeeThruEquity Initiates Coverage on Verisante Technology, Inc.

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 14, 2013) - Verisante Technology, Inc. (TSX VENTURE:VRS) (OTCQX:VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that SeeThruEquity, an investment research firm, has initiated coverage on the Company with a fair value of $1.05 per share.

SeeThruEquity provides research on companies with market capitalizations below $1 billion. The report on Verisante is now available for download - click here for the initiation report.
About SeeThruEquity, LLC

SeeThruEquity, LLC is an investment research and corporate access firm that produces high quality research reports on smallcap and microcap companies with less than $1 billion in market capitalization. These companies have typically been underserved by the traditional Wall Street analyst establishment. We are unfettered by any ties to investment banking or trading, and distribute our high impact research as an approved firm for consensus estimates on Thomson Reuters, CapitalIQ, FactSet, Zacks and StockTwits, as well as to our own audience of investors from our corporate website.

The investment opinions expressed are solely those of SeeThruEquity. SeeThruEquity has not been compensated for the preparation of its report on the Company by any third party or the Company.


Bullboard Posts